Design Therapeutics Inc (DSGN)
5.56
+0.24
(+4.51%)
USD |
NASDAQ |
Nov 05, 16:00
5.56
0.00 (0.00%)
After-Hours: 16:00
Design Therapeutics Shareholders Equity (Quarterly): 261.24M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 261.24M |
| March 31, 2024 | 269.56M |
| December 31, 2023 | 277.69M |
| September 30, 2023 | 284.96M |
| June 30, 2023 | 296.80M |
| March 31, 2023 | 312.82M |
| December 31, 2022 | 327.31M |
| September 30, 2022 | 340.94M |
| Date | Value |
|---|---|
| June 30, 2022 | 357.16M |
| March 31, 2022 | 370.31M |
| December 31, 2021 | 382.13M |
| September 30, 2021 | 391.56M |
| June 30, 2021 | 401.60M |
| March 31, 2021 | 408.01M |
| December 31, 2020 | -11.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.32M
Minimum
Dec 2020
408.01M
Maximum
Mar 2021
311.38M
Average
327.31M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 269.58M |
| Total Liabilities (Quarterly) | 8.34M |